Key terms
About OMCL
Omnicell, Inc. engages in the provision of medication management automation solutions and adherence tools for healthcare systems and pharmacies. Its solutions include intelligence, platform and interoperability, central pharmacy dispensing, medication adherence, population health and point of care automation. The company was founded by Randall A. Lipps in September 1992 and is headquartered in Fort Worth, TX.
Sector
Industry
Employees
Founded
Website
Key stock statistics
1-day range
52-week range
Market cap
P/E ratio
Next earnings date
Dividend yield
Ex-dividend date
Dividend pay date
Key terms
Ad Feedback
Smart score
Latest OMCL news
Today
7:07am ET
Analysts Offer Insights on Healthcare Companies: Day One Biopharmaceuticals (DAWN), Amgen (AMGN) and Omnicell (OMCL)
Today
7:07am ET
BTIG Sticks to Its Hold Rating for Omnicell (OMCL)
Today
6:42am ET
Barclays Sticks to Its Sell Rating for Omnicell (OMCL)
Yesterday
8:27am ET
Omnicell backs FY24 EPS view 90c-$1.40, consensus $1.07
Yesterday
8:22am ET
Omnicell sees Q2 EPS 10c-20c, consensus 27c
Yesterday
8:21am ET
Omnicell reports Q1 EPS (34c), consensus (9c)
Apr 30
7:11am ET
Analysts Offer Insights on Healthcare Companies: Omnicell (OMCL), AnaptysBio (ANAB) and LivaNova (LIVN)
Apr 22
4:13pm ET
Clover Health appoints Peter Kuipers as CFO
Apr 17
8:55am ET
Omnicell (OMCL) Receives a Buy from Craig-Hallum
Apr 17
5:07am ET
Omnicell’s Strategic Shift to Recurring Revenue: A Cautious Hold Amidst Transformation Uncertainty
Apr 16
4:13pm ET
Omnicell announces XT Amplify
Apr 03
5:40am ET
Analysts Offer Insights on Healthcare Companies: Eli Lilly & Co (LLY), Glaukos (GKOS) and Omnicell (OMCL)
Mar 01
6:56am ET
Omnicell’s Steady Demand and Modest Revenue Projections Justify Hold Rating
Feb 29
4:25pm ET
Omnicell Announces Executive Retirement and New VP Appointment
Feb 09
7:14am ET
Omnicell price target lowered to $38 from $42 at Benchmark
Feb 09
6:09am ET
Omnicell price target lowered to $26 from $28 at Wells Fargo
Feb 09
5:38am ET
Omnicell price target lowered to $26 from $33 at Barclays
Feb 09
5:20am ET
Analysts’ Top Healthcare Picks: Merck & Company (MRK), Omnicell (OMCL)
Feb 09
3:40am ET
Analysts Offer Insights on Healthcare Companies: Omnicell (OMCL), Replimune Group (REPL) and Phibro Animal Health (PAHC)
Feb 08
7:55pm ET
Omnicell Hold Rating: Recovery and Transformation Amidst Financial Uncertainties
Feb 08
8:16am ET
Omnicell sees FY24 EPS 90c-$1.40, consensus $1.66
Feb 08
8:13am ET
Omnicell sees Q1 EPS (10c)-0c, consensus 31c
Feb 08
8:11am ET
Omnicell reports Q4 EPS 33c, consensus 15c
Feb 07
7:31am ET
Analysts Offer Insights on Healthcare Companies: Gilead Sciences (GILD), Edwards Lifesciences (EW) and Omnicell (OMCL)
Feb 05
9:06am ET
Positive Report for Omnicell (OMCL) from Craig-Hallum
No recent press releases are available for OMCL
OMCL Financials
Key terms
Ad Feedback
OMCL Forecasts
analyst rating
- buy
- hold
- sell
1-year stock price forecast
OMCL Competitors
$ Market cap
P/E ratio
$ Price
1d change
52-week range
